Crea il mio profilo
Accesso pubblico
Visualizza tutto32 articoli
2 articoli
Disponibili
Non disponibili
In base ai mandati di finanziamento
Coautori
- Ton N.M. SchumacherThe Netherlands Cancer Institute, Third Rock VenturesEmail verificata su nki.nl
- Benoit P NicoletNetherlands Cancer Institute (NKI)Email verificata su nki.nl
- EF. SmitHoogleraar longziektenEmail verificata su nki.nl
- Julian J. Freen-van HeerenSanquin Health Solutions, R&D, Immunomonitoring LaboratoryEmail verificata su sanquin.nl
- Marieke von lindernSanquin Research, and Landsteiner Lab. AMC/UvAEmail verificata su sanquin.nl
- Hans CleversHubrecht Institute - UtrechtEmail verificata su hubrecht.eu
- emile voestEmail verificata su nki.nl
- jan paul medemaHoogleraar Exp Oncology and RadiobiologyEmail verificata su amc.nl
- Stephen P. SchoenbergerLa Jolla Institute for ImmunologyEmail verificata su lji.org
- Maartje van den BiggelaarEmail verificata su sanquin.nl
- Derk AmsenEmail verificata su amc.nl
- Maarten SlagterNetherlands Cancer InstituteEmail verificata su nki.nl
- Joris van de HaarDivision of Molecular Oncology & Immunology, The Netherlands Cancer Institute, AmsterdamEmail verificata su nki.nl
- Emile van den AkkerSanquinEmail verificata su sanquin.nl
- Martin TurnerThe Babraham Institute, Cambridge, CB22 3AT, UK.Email verificata su babraham.ac.uk
- Julien J. KARRICHPostdoctoral fellowEmail verificata su sanquin.nl
- Jan NicoBouwes BavinckJan Nico Bouwes BavinckEmail verificata su lumc.nl
- Ramon ArensLeiden UniversityEmail verificata su lumc.nl
- S.C. JamesonUniversity of MinnesotaEmail verificata su umn.edu
- Sara E. HamiltonEmail verificata su umn.edu